Oticon Reveal. Demant—parent company of Oticon , Bernafon , HearingLife , and some of the hearing industry’s most prominent diagnostic equipment brands—raised its full-year financial outlook after preliminary third-quarter results showed a 17% organic increase in hearing aid revenue from external customers, measured by sales value rather than units sold....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a financial performance report with no clinical or patient-care implications.
A 17% organic growth surge at Demant signals continued strong consumer demand for hearing aids and reinforces the competitive pressure on the broader hearing healthcare market.
- 01Demant reported 17% organic revenue growth in hearing aids for Q3 2026.
- 02Preliminary results prompted an upward revision to the company's full-year 2026 financial outlook.
- 03The Oticon Reveal was cited as a key product driving sales performance.
- 04Growth reflects broader market momentum in hearing aid adoption.
Demant achieved 17% organic growth in hearing aid revenue in Q3 2026.
press releasepartially supportedThe Oticon Reveal was among the key products driving Demant's Q3 sales surge.
press releasepartially supported
